CONSOLIDATED INCOME STATEMENT - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|
| Income Statement [Abstract] | ||||
| Revenues | $ 621,861 | $ 591,187 | $ 1,216,642 | $ 1,162,601 |
| Cost of service, inclusive of depreciation | 348,470 | 326,933 | 682,520 | 648,470 |
| General and administrative expenses: | ||||
| Salaries and benefits | 130,322 | 129,323 | 262,290 | 257,269 |
| Non-cash compensation | 7,266 | 7,828 | 13,489 | 15,261 |
| Merger-related expenses | 26,277 | 11,901 | 43,046 | 32,568 |
| Depreciation and amortization | 4,372 | 4,386 | 8,819 | 8,657 |
| Impairment | 883 | 0 | 883 | 0 |
| Other | 58,693 | 58,602 | 116,658 | 116,543 |
| Total operating expenses | 576,283 | 538,973 | 1,127,705 | 1,078,768 |
| Operating income | 45,578 | 52,214 | 88,937 | 83,833 |
| Other income (expense): | ||||
| Interest income | 3,016 | 1,617 | 5,889 | 3,344 |
| Interest expense | (6,415) | (7,895) | (12,837) | (16,014) |
| Equity in earnings from equity method investments | 1,641 | 1,515 | 3,435 | 2,425 |
| Gain on equity method investment | 0 | 0 | 48,093 | 0 |
| Miscellaneous, net | 4,506 | 1,779 | 6,014 | 2,869 |
| Total other income (expense), net | 2,748 | (2,984) | 50,594 | (7,376) |
| Income before income taxes | 48,326 | 49,230 | 139,531 | 76,457 |
| Income tax expense | (19,274) | (16,657) | (48,658) | (29,290) |
| Net income | 29,052 | 32,573 | 90,873 | 47,167 |
| Net income attributable to noncontrolling interests | (968) | (272) | (1,777) | (466) |
| Net income attributable to Amedisys, Inc. | $ 28,084 | $ 32,301 | $ 89,096 | $ 46,701 |
| Basic earnings per common share: | ||||
| Net income attributable to Amedisys, Inc. common stockholders | $ 0.85 | $ 0.99 | $ 2.71 | $ 1.43 |
| Weighted average shares outstanding, basic (shares) | 32,849 | 32,706 | 32,822 | 32,688 |
| Diluted earnings per common share: | ||||
| Net income attributable to Amedisys, Inc. common stockholders | $ 0.84 | $ 0.98 | $ 2.68 | $ 1.42 |
| Weighted average shares outstanding, diluted (shares) | 33,289 | 33,047 | 33,231 | 32,992 |
| X | ||||||||||
- Definition Merger-related expenses No definition available.
|
| X | ||||||||||
- Definition Non-cash compensation excluding merger-related expenses No definition available.
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (loss) for proportionate share of equity method investee's income (loss). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of general and administrative expense classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|